PharVision Advisers’s PubMatic PUBM Stock Holding History

PharVision Advisers’s Portfolio PUBM Stock Details PUBM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45,735	Closed	-$406K	–	521
2025 Q4	$406K	Buy	+45,735	New	+$398K	0.21%	117

Other funds holding PUBM

GHC

Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's PUBM Position: Q1 2026 in Review

PharVision Advisers sold out of PubMatic (PUBM) in Q1 2026, closing a stake of 45,735 shares — an estimated $406K sold.

PharVision Advisers first reported a position in PUBM in Q4 2025 and held it in 1 quarter. The position peaked at $406K in Q4 2025. 153 funds tracked by Wall St. Rank hold PUBM as of Q1 2026.

PharVision Advisers reported no remaining PubMatic position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 45,735 PubMatic shares in Q1 2026, an estimated $406K.
PharVision Advisers first reported a position in PubMatic in Q4 2025 and held it in 1 quarter.
PharVision Advisers's PubMatic position peaked at $406K in Q4 2025.
153 funds tracked by Wall St. Rank held PubMatic as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.